General Information
Product name
Anise star oil, natural
CAS No.
68952-43-2
1.2.2. Uses advised against
Industrial. For professional use only
Emergency telephone
91 98200 41841
Icons in SDS
Company Information
company name
OTTO CHEMIE PVT LTD
e-mail address of the competent person responsible for the Safety Data Sheet
info@ottokemi.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H411
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H317 May cause an allergic skin reaction. H411 Toxic to aquatic life with long lasting effects. none Reduced Labeling (<= 125 ml) H317 May cause an allergic skin reaction. none
Precautionary statements
P273 Avoid release to the environment. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Skin sensitization (Category 1), H317 Long-term (chronic) aquatic hazard (Category 2), H411 For the full text of the H-Statements mentioned in this Section, see Section 16.
